Ion-Channel Epilepsy Program
Part of the nationally recognized Nicklaus Children's Neuroscience Institute, the Ion-Channel Epilepsy (Dravet syndrome) Program provides comprehensive care for children with genetically based epilepsy referred from all over the country.
The multidisciplinary team includes neurologists and genetics specialists and offers diagnostic screening and the latest medical management, including participation in emerging clinical trials.
Clinical Trials
-
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet SyndromeStudy ID:Principal Investigator:
-
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)Study ID:Principal Investigator:
-
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)Study ID:Principal Investigator:



